HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).

Abstract
A preliminary report is presented of prospective, randomized study with continuous and intermittent oral Estracyt treatment in patients with prostatic carcinoma. It seems that the therapeutic effect of intermittent treatment is as favorable as continuous therapy. Side effects and costs are lower with intermittent therapy.
AuthorsW Vahlensieck, G Wegner
JournalScandinavian journal of urology and nephrology. Supplementum (Scand J Urol Nephrol Suppl) Vol. 55 Pg. 147-9 ( 1980) ISSN: 0300-8886 [Print] England
PMID6938018 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nitrogen Mustard Compounds
  • Estramustine
Topics
  • Drug Administration Schedule
  • Estramustine (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Male
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Nitrogen Mustard Compounds (administration & dosage)
  • Prostatic Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: